Company intelligence / Profile preview

Ripple Biosolutions

Seattle, Washington, United Statesripplebiosol.com ↗

Ownership: Private
Development stage: Other

Overview

Ripple Biosolutions supplies highly purified circulating cell-free DNA (cfDNA) isolated from single-source healthy human donors. Their flagship product, IsoPure cfDNA, is designed for use in research and development of diagnostic assays. The product offers native cfDNA with minimal contamination by high-molecular weight genomic DNA and is intended to improve the reliability and real-world relevance of diagnostic assay development.

Modalities: Cell-free DNA (cfDNA) products (as research tools, not therapeutics)
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Ripple Biosolutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ripple Biosolutions.

Explore the full profile